» Articles » PMID: 36132896

Graphene Quantum Dots in Photodynamic Therapy

Overview
Journal Nanoscale Adv
Specialty Biotechnology
Date 2022 Sep 22
PMID 36132896
Authors
Affiliations
Soon will be listed here.
Abstract

Graphene quantum dots (GQDs) have shown great promise in a variety of medical applications. Recently, it has been found that GQDs are also beneficial for photodynamic therapy (PDT). However, the findings of GQDs as PDT agents have been controversial in the literature. Herein, we investigate the photoactivity of single-atomic-layered GQDs by examining their ability to generate singlet oxygen (O) under irradiation and their effects on the photoactivity of photosensitizers. We demonstrate that the GQDs with lateral sizes of ∼5 or 20 nm are photo-inactive for they cannot generate O under irradiation of either a 660 nm laser (105 mW cm) or a halogen light. Moreover, the GQDs inhibit the photoactivity of two classical photosensitizers, namely, methylene blue and methylene violet. The stronger interaction between the GQDs and the photosensitizer results in greater inhibition of GQDs. Besides, the large-sized GQDs exhibit stronger inhibition than the small-sized GQDs. The inhibitory effect of the GQDs on the photoactivity of photosensitizers is consistent with their photo-cytotoxicity. These results indicate that the single-atomic-layered GQDs are not potential PDT agents, but they may be helpful for photosensitizers by delivering them into the cells. The discrepancy between the current work and the literature is probably associated with the GQDs used.

Citing Articles

Advances in smart nanotechnology-supported photodynamic therapy for cancer.

Li G, Wang C, Jin B, Sun T, Sun K, Wang S Cell Death Discov. 2024; 10(1):466.

PMID: 39528439 PMC: 11554787. DOI: 10.1038/s41420-024-02236-4.


Graphene Quantum Dots from Natural Carbon Sources for Drug and Gene Delivery in Cancer Treatment.

Osorio H, Castillo-Solis F, Barragan S, Rodriguez-Polit C, Gonzalez-Pastor R Int J Mol Sci. 2024; 25(19).

PMID: 39408866 PMC: 11476599. DOI: 10.3390/ijms251910539.


Graphene quantum dot-crafted nanocomposites: shaping the future landscape of biomedical advances.

Dar M, Sahu N Discov Nano. 2024; 19(1):79.

PMID: 38695997 PMC: 11065842. DOI: 10.1186/s11671-024-04028-2.


Compounding Methylene Blue with Selenium-decorated Graphene Quantum Dots to Improve Singlet Oxygen Production for Photodynamic Therapy Application.

Khorshidi A, Bahari A, Hamidabadi V J Fluoresc. 2024; .

PMID: 38619731 DOI: 10.1007/s10895-024-03719-4.


Theranostic Applications of 2D Graphene-Based Materials for Solid Tumors Treatment.

Iannazzo D, Celesti C, Giofre S, Ettari R, Bitto A Nanomaterials (Basel). 2023; 13(16).

PMID: 37630966 PMC: 10459055. DOI: 10.3390/nano13162380.


References
1.
Kuo W, Chen H, Chen S, Chang C, Chen P, Hou Y . Graphene quantum dots with nitrogen-doped content dependence for highly efficient dual-modality photodynamic antimicrobial therapy and bioimaging. Biomaterials. 2017; 120:185-194. DOI: 10.1016/j.biomaterials.2016.12.022. View

2.
Detty M, Gibson S, Wagner S . Current clinical and preclinical photosensitizers for use in photodynamic therapy. J Med Chem. 2004; 47(16):3897-915. DOI: 10.1021/jm040074b. View

3.
Wang X, Sun X, Lao J, He H, Cheng T, Wang M . Multifunctional graphene quantum dots for simultaneous targeted cellular imaging and drug delivery. Colloids Surf B Biointerfaces. 2014; 122:638-644. DOI: 10.1016/j.colsurfb.2014.07.043. View

4.
van Straten D, Mashayekhi V, de Bruijn H, Oliveira S, Robinson D . Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions. Cancers (Basel). 2017; 9(2). PMC: 5332942. DOI: 10.3390/cancers9020019. View

5.
Zhou Y, Sun H, Wang F, Ren J, Qu X . How functional groups influence the ROS generation and cytotoxicity of graphene quantum dots. Chem Commun (Camb). 2017; 53(76):10588-10591. DOI: 10.1039/c7cc04831a. View